The effectiveness of this multifaceted intervention has not been previously examined in a randomized trial targeting individuals with type 2 diabetes who have high rates of cardiovascular disease morbidity and mortality as well as a high risk for secondary and tertiary medical complications if glycemic control is not achieved and maintained.